Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENDOXAN INJ Cause T-cell lymphoma recurrent? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of T-cell lymphoma recurrent have been filed in association with ENDOXAN INJ. This represents 9.4% of all adverse event reports for ENDOXAN INJ.

10
Reports of T-cell lymphoma recurrent with ENDOXAN INJ
9.4%
of all ENDOXAN INJ reports
0
Deaths
0
Hospitalizations

How Dangerous Is T-cell lymphoma recurrent From ENDOXAN INJ?

Of the 10 reports.

Is T-cell lymphoma recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENDOXAN INJ. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does ENDOXAN INJ Cause?

Disease progression (64) Death (15) Febrile neutropenia (11) Adverse event (8) Pneumonia (5)

What Other Drugs Cause T-cell lymphoma recurrent?

DOXORUBICIN (14) PREDNISONE (14) VINCRISTINE (13) RITUXIMAB (10) SULFAMETHOXAZOLE (10) TRIMETHOPRIM (10) CYCLOPHOSPHAMIDE (5)

Which ENDOXAN INJ Alternatives Have Lower T-cell lymphoma recurrent Risk?

ENDOXAN INJ vs ENDOXAN , POUDRE POUR ENDOXAN INJ vs ENOXAPARIN ENDOXAN INJ vs ENTECAVIR ENDOXAN INJ vs ENZALUTAMIDE ENDOXAN INJ vs EPCORITAMAB

Related Pages

ENDOXAN INJ Full Profile All T-cell lymphoma recurrent Reports All Drugs Causing T-cell lymphoma recurrent ENDOXAN INJ Demographics